ArticleFrontiers in pharmacology2023

Comparative evaluation of clinical glycemic control markers treated with imeglimin and its effect on erythrocytes in patients with type 2 diabetes mellitus: study protocol of a single-arm, open-label, prospective, exploratory trial.

Takeshi Osonoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.